Last reviewed · How we verify
NCT03265769
Femoral or Radial Approach in Coronary Chronic Total Occlusion
NA trial testing radial access site in Chronic Coronary Occlusion in 610 participants. Completed in 8 July 2021.
8 July 2021
Quick facts
| Lead sponsor | Acibadem University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 610 |
| Start date | 8 August 2017 |
| Primary completion | 8 July 2021 |
| Estimated completion | 8 July 2021 |
| Sites | 4 locations across Turkey (Türkiye) |
Drugs / interventions tested
- radial access site
- femoral access site
Conditions studied
- Chronic Coronary Occlusion — all drugs for Chronic Coronary Occlusion →
Sponsor
Acibadem University
Who can join
Adults 18 to 90, any sex, with Chronic Coronary Occlusion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pecutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is most commonly performed using bilateral transfemoral access and 8 French guiding catheters. However, transfemoral approach (TFA) is associated with higher risk of vascular access complications.5 It has been reported that using transradial approach (TRA) reduces vascular complications and may be associated with a better clinical outcome. Transradial access is also used in complex PCI interventions.There is a growing body of evidence regarding the use of this approach also in CTO procedures. In available literature, all studies comparing TRA vs. TFA in CTO consisted of single center and single operator experience. Besides, none of them is randomized. To fill in the gap, we sought to examine the technique and outcomes of transradial vs. transfemoral CTO PCI in a contemporary multicenter randomized study.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Femoral or Radial Approach in Treatment of Coronary Chronic Total Occlusion: A Randomized Clinical Trial.
Gorgulu S, Kalay N, Norgaz T, Kocas C, et al · · 2022 · cited 25× · PMID 35450683 · DOI 10.1016/j.jcin.2022.02.012
Verify or expand the search:
- PubMed search for NCT03265769
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Acibadem University trials
Trials by the same sponsor.
- NCT07481864 — The Effect of Early-Phase Graded Motor Imagery Following Massive Rotator Cuff Repair. · NA · not yet recruiting
- NCT07488377 — Turkish Cognitive Self-Efficacy Questionnaire in Parkinson's Disease · not yet recruiting
- NCT07488364 — Determinants of Physical Frailty in Parkinson's Disease: A Multi-Factorial Analysis · not yet recruiting
- NCT07488351 — "Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life" · not yet recruiting
- NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03265769 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Acibadem University
- Last refreshed: 13 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03265769.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing